Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity

Nat Immunol. 2022 Aug;23(8):1193-1207. doi: 10.1038/s41590-022-01269-0. Epub 2022 Jul 25.

Abstract

Innate antiviral immunity deteriorates with aging but how this occurs is not entirely clear. Here we identified SIRT1-mediated DNA-binding domain (DBD) deacetylation as a critical step for IRF3/7 activation that is inhibited during aging. Viral-stimulated IRF3 underwent liquid-liquid phase separation (LLPS) with interferon (IFN)-stimulated response element DNA and compartmentalized IRF7 in the nucleus, thereby stimulating type I IFN (IFN-I) expression. SIRT1 deficiency resulted in IRF3/IRF7 hyperacetylation in the DBD, which inhibited LLPS and innate immunity, resulting in increased viral load and mortality in mice. By developing a genetic code expansion orthogonal system, we demonstrated the presence of an acetyl moiety at specific IRF3/IRF7 DBD site/s abolish IRF3/IRF7 LLPS and IFN-I induction. SIRT1 agonists rescued SIRT1 activity in aged mice, restored IFN signaling and thus antagonized viral replication. These findings not only identify a mechanism by which SIRT1 regulates IFN production by affecting IRF3/IRF7 LLPS, but also provide information on the drivers of innate immunosenescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents*
  • Immunity, Innate
  • Interferon Regulatory Factor-3 / metabolism
  • Interferon Regulatory Factor-7 / genetics
  • Interferon Regulatory Factor-7 / metabolism
  • Mice
  • Signal Transduction
  • Sirtuin 1* / genetics
  • Sirtuin 1* / metabolism
  • Virus Replication

Substances

  • Antiviral Agents
  • Interferon Regulatory Factor-3
  • Interferon Regulatory Factor-7
  • Irf3 protein, mouse
  • Irf7 protein, mouse
  • Sirt1 protein, mouse
  • Sirtuin 1